Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: A Case Series

NCT03574506 is registered in ClinicalTrials.gov with Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia as lead sponsor.

NCT NCT03574506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: A Case Series
Lead sponsor
Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia
Phase
Observational
Overall status
Unknown status
Start date
April 15, 2018
Completion date
November 30, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hemolytic uremic syndrome, pregnancy